Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Paridaans, Maarten P M"'
Autor:
Lobatto, Mark E., Calcagno, Claudia, Otten, Maarten J., Millon, Antoine, Ramachandran, Sarayu, Paridaans, Maarten P M, van der Valk, Fleur M., Storm, G, Stroes, Erik S G, Fayad, Zahi A., Mulder, Willem J M, Metselaar, Josbert M., Pharmaceutics, Sub Drug targeting, Sub General Pharmaceutics
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine
Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier, 2015, 11 (5), pp.1133-40. ⟨10.1016/j.nano.2015.02.020⟩
Nanomedicine: nanotechnology, biology and medicine, 11(5), 1133-1140. Elsevier Inc.
Nanomedicine, 11(5), 1133-1140. Future Medicine Ltd.
Nanomedicine : nanotechnology, biology and medicine, 11(5), 1133. Elsevier
Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier, 2015, 11 (5), pp.1133-40. ⟨10.1016/j.nano.2015.02.020⟩
Nanomedicine: nanotechnology, biology and medicine, 11(5), 1133-1140. Elsevier Inc.
Nanomedicine, 11(5), 1133-1140. Future Medicine Ltd.
Nanomedicine : nanotechnology, biology and medicine, 11(5), 1133. Elsevier
International audience; The present study describes the development of a good manufacturing practice (GMP)-grade liposomal nanotherapy containing prednisolone phosphate for the treatment of inflammatory diseases. After formulation design, GMP product
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e79ed09ed8f998ca03ede8ef7ef7a4a7
https://doi.org/10.1016/j.nano.2015.02.020
https://doi.org/10.1016/j.nano.2015.02.020
Autor:
Lobatto, Mark E., Calcagno, Claudia, Millon, Antoine, Senders, Max L., Fay, Francois, Robson, Philip M., Ramachandran, Sarayu, Binderup, Tina, Paridaans, Maarten P M, Sensarn, Steven, Rogalla, Stephan, Gordon, Ronald E., Cardoso, Luis, Storm, G, Metselaar, Josbert M., Contag, Christopher H., Stroes, Erik S G, Fayad, Zahi A., Mulder, Willem J M, Pharmaceutics, Sub Drug targeting, Sub General Pharmaceutics
Publikováno v:
ACS Nano
ACS Nano, American Chemical Society, 2015, 9 (2), pp.1837-47. ⟨10.1021/nn506750r⟩
ACS Nano, 9(2), 1837. American Chemical Society
ACS nano, 9(2), 1837-1847. American Chemical Society
ACS Nano, American Chemical Society, 2015, 9 (2), pp.1837-47. ⟨10.1021/nn506750r⟩
ACS Nano, 9(2), 1837. American Chemical Society
ACS nano, 9(2), 1837-1847. American Chemical Society
International audience; Atherosclerosis is a major cause of global morbidity and mortality that could benefit from novel targeted therapeutics. Recent studies have shown efficient and local drug delivery with nanoparticles, although the nanoparticle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b56e4b05c666fe4e498ac642049fa52c
https://hal.archives-ouvertes.fr/hal-01850477
https://hal.archives-ouvertes.fr/hal-01850477
Autor:
van der Valk, Fleur M., van Wijk, Diederik F., Lobatto, Mark E., Verberne, Hein J., Storm, G, Willems, Martine C M, Legemate, Dink A., Nederveen, Aart J., Calcagno, Claudia, Mani, Venkatesh, Ramachandran, Sarayu, Paridaans, Maarten P M, Otten, Maarten J., Dallinga-Thie, Geesje M., Fayad, Zahi A., Nieuwdorp, Max, Schulte, Dominik M., Metselaar, Josbert M., Mulder, Willem J M, Stroes, Erik S., Pharmaceutics, Sub Drug targeting, Sub General Pharmaceutics
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine, 11(5), 1039-1046. Elsevier Inc.
van der Valk, F M, van Wijk, D F, Lobatto, M E, Verberne, H J, Storm, G, Willems, M C, Legemate, D A, Nederveen, A J, Calcago, C, Mani, V, Ramachandran, S, Paridaans, M P, Otten, M J, Dallinga-Thie, G M, Fayad, Z A, Nieuwdorp, M, Schulte, D M, Metselaar, J M, Mulder, W J & Stroes, E S 2015, ' Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration ', Nanomedicine: Nanotechnology, Biology and Medicine, vol. 11, no. 5, pp. 1039-1046 . https://doi.org/10.1016/j.nano.2015.02.021
Nanomedicine : nanotechnology, biology and medicine, 11(5), 1039. Elsevier
Nanomedicine: nanotechnology, biology and medicine, 11(5), 1039-1046. Elsevier Inc.
Nanomedicine, 11(5), 1039-1046. Future Medicine Ltd.
van der Valk, F M, van Wijk, D F, Lobatto, M E, Verberne, H J, Storm, G, Willems, M C, Legemate, D A, Nederveen, A J, Calcago, C, Mani, V, Ramachandran, S, Paridaans, M P, Otten, M J, Dallinga-Thie, G M, Fayad, Z A, Nieuwdorp, M, Schulte, D M, Metselaar, J M, Mulder, W J & Stroes, E S 2015, ' Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration ', Nanomedicine: Nanotechnology, Biology and Medicine, vol. 11, no. 5, pp. 1039-1046 . https://doi.org/10.1016/j.nano.2015.02.021
Nanomedicine : nanotechnology, biology and medicine, 11(5), 1039. Elsevier
Nanomedicine: nanotechnology, biology and medicine, 11(5), 1039-1046. Elsevier Inc.
Nanomedicine, 11(5), 1039-1046. Future Medicine Ltd.
Drug delivery to atherosclerotic plaques via liposomal nanoparticles may improve therapeutic agents' risk-benefit ratios. Our paper details the first clinical studies of a liposomal nanoparticle encapsulating prednisolone (LN-PLP) in atherosclerosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da172a658871cd4b790b58eeb16828fd
https://research.vumc.nl/en/publications/2bd71361-36b3-4c16-aef7-5a14fb3f5710
https://research.vumc.nl/en/publications/2bd71361-36b3-4c16-aef7-5a14fb3f5710
Autor:
Lobatto ME; Translational and Molecular Imaging Institute, Department of Radiology, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, New York, New York 10029, United States., Calcagno C, Millon A, Senders ML, Fay F, Robson PM, Ramachandran S, Binderup T, Paridaans MP, Sensarn S, Rogalla S, Gordon RE, Cardoso L, Storm G, Metselaar JM, Contag CH, Stroes ES, Fayad ZA, Mulder WJ
Publikováno v:
ACS nano [ACS Nano] 2015 Feb 24; Vol. 9 (2), pp. 1837-47. Date of Electronic Publication: 2015 Jan 28.